摘要
吉西他滨是一种嘧啶核苷类似物,具有抗瘤谱广、毒副反应轻等特点,被广泛地应用于非小细胞肺癌、乳腺癌、膀胱癌、胰腺癌等各种实体瘤治疗领域中。本文综述吉西他滨联合放疗治疗局部晚期非小细胞肺癌的研究进展。
Gemcitabine, 2', 2' - difluorodeoxycytidine is a novel antimetabolite that acts via inhibition of DNA synthesis. Gemcitabine has shown broad clinical anti - tumor activity for the chemotherapy of advanced non- small cell lung cancer, pancreatic cancer, and bladder cancer. This paper is to review data of gemcitabine in combined with raiotherapy for the treatmnent of local advanced NSCLC.
出处
《癌症进展》
2006年第5期444-446,共3页
Oncology Progress
关键词
吉西他滨
非小细胞肺癌
gemcitabine non- small cell lung cancer